Patent details
300835 Product Name: Eftrenonacog alfa
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- 300835
- Type:
- Certificate
- SPC Type:
- Medical
- Basic Patent Number:
- EP2298347
- Status:
- SPC in force
- Application number:
- 300835
- Procedural language:
- Dutch
- First Applicant Residence Country:
- United States of America (US)
Marketing Authorization
- Marketing Authorization Number:
- EU/1/16/1098
- Marketing Authorization Type:
- EEA
- Marketing Authorization Date:
- 13/05/2016
- Marketing Authorization Country:
- European Union (EU)
Dates
- Filing date:
- 14/10/2016
- First Marketing Authorization date:
- 13/05/2016
- Grant date:
- 16/03/2017
- Activation date:
- 06/05/2024
- Lapsed By Non Payment Annual Fee Date:
- Renunciation Date:
- NullificationDate:
- Registration date:
- 17/10/2016
- SPC/SPC Extension Expiration Date:
- 05/05/2029
- Lapsed By Expiration Date:
- Withdrawal date:
- Revocation Date:
- Invalidity Date:
- Withdrawal Market Authorization Date:
- Refusal Date:
Applicant/holder
- From:
- 16/11/2017
- Name:
- Bioverativ Therapeutics Inc.
- Address:
- 225 Second Avenue, 02451, Waltham, MA, United States of America (US)
Historical Applicant/holder
- From:
- 16/11/2017
- To:
- 16/11/2017
- Name:
- Bioverativ Therapeutics Inc.
- Address:
- 225 Second Avenue, 02451, Waltham, MA, United States of America (US)
- From:
- 17/10/2016
- To:
- 11/04/2017
- Name:
- Biogen Hemophilia Inc.
- Address:
- 250 Binney Street, Cambridge MA 02142, United States of America (US)
Agent
- Name:
- ir. F.A. Geurts c.s.
- From:
- 17/10/2016
- Address:
- Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC
- Journal edition number:
- 19/24
- Publication date:
- 08/05/2024
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
2
- Bulletin Heading:
- CO
- Journal edition number:
- 25/17
- Publication date:
- 21/06/2017
- Description:
- Changes in the Netherlands Patent Register
3
- Bulletin Heading:
- SPC
- Journal edition number:
- 12/17
- Publication date:
- 22/03/2017
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
4
- Bulletin Heading:
- SPC
- Journal edition number:
- 42/16
- Publication date:
- 19/10/2016
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Deed
Change of Address
- Change Kind/ Decision Type:
- Owner
- Deed Number:
- RC201702274A
- Date Registered:
- 16/11/2017
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. M.F.J.M. Ketelaars c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Change of owner(s)
- Change Kind/ Decision Type:
- Change of owner(s) name
- Deed Number:
- RC201700883A
- Date Registered:
- 11/04/2017
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. M.F.J.M. Ketelaars c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Owner(s)
- Name:
- Bioverativ Therapeutics Inc.
- Address:
- 250 Binney Street, 02451, Cambridge, MA 02142, United States of America (US)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Annual Fee
- Annual Fee(s) Due Date:
- 31/05/2026
- Annual Fee Number:
- 23
- Annual Fee Amount:
- 2000 Euro
- Last Annual Payment Date:
- 22/04/2025
- Last Annual Fee Paid Number:
- 22
- Last Annual Fee Paid Amount:
- 1800 Euro
- Payer:
- Arnold & Siedsma BV
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 16/03/2017 | SPC Documents | Certificate SPC | 1 | /4/2/8/7/9/0800097824/docs/300835_1_supplprotectioncertificate20170317015734947.pdf | ||
| 16/03/2017 | Outgoing Correspondence | Decision grant | 1 | /4/2/8/7/9/0800097824/docs/300835_3_outgoingcorrespondence20170317015734873.pdf | ||
| 15/02/2017 | SPC Documents | Accompanying letter SPC | 1 | /4/2/8/7/9/0800097824/docs/300835_6_supplprotectioncertificate20210111010210234.pdf | ||
| 06/12/2016 | Outgoing Correspondence | Letter to applicant | 2 | /4/2/8/7/9/0800097824/docs/300835_7_outgoingcorrespondence20161207062011877.pdf | ||
| 18/10/2016 | Outgoing Correspondence | Confirmation receipt request | 1 | /4/2/8/7/9/0800097824/docs/300835_5_outgoingcorrespondence20210111125819400.pdf | ||
| 14/10/2016 | SPC Documents | Marketing Authorization SPC | 3 | /4/2/8/7/9/0800097824/docs/300835_0_supplprotectioncertificate20161014032823586.pdf | ||
| 14/10/2016 | Application Form | First filed application form | 3 | /4/2/8/7/9/0800097824/docs/300835_2_applicationform20161014032823452.pdf | ||
| 14/10/2016 | SPC Documents | Annex SPC | 1 | /4/2/8/7/9/0800097824/docs/300835_4_supplprotectioncertificate20210111125444020.pdf | ||
| 14/10/2016 | SPC Documents | Summary of the characteristics of the product | 16 | /4/2/8/7/9/0800097824/docs/300835_8_supplprotectioncertificate20161014032823702.pdf |